Message Font: Serif | Sans-Serif
No. of Recommendations: 1
Good morning,

Today the Wall Street Journal reported, in its online edition, Boston Scientificis is moving closer to striking a deal to buy the 80 percent it doesn't already own of Isreali medical device concern Medinol.

Boston Scientific currently holds 22 pct of Medinol while the Israeli company's founders -- Kobi and Judith Richter -- own 64 percent and another founder holds the rest. Medinol employs 150 people in Israel.

Medinol has developed a range of new stents under the NIR trade name, including the NIRFLEX, with improved rigidity and flexibility. According to the source, the problem has been delays in the development of delivery systems for the new stents.

While Medinol develops the stents, Boston Scientific makes the delivery devices, called balloons.

According to the source Medinol's value lies not only in its stents but also in its efficient manufacturing process, resulting in low production costs and profit margins of up to 90 percent.

To see the entire story click on the news link @ the top of this page.

Best wishes,

Print the post  


When Life Gives You Lemons
We all have had hardships and made poor decisions. The important thing is how we respond and grow. Read the story of a Fool who started from nothing, and looks to gain everything.
Contact Us
Contact Customer Service and other Fool departments here.
Work for Fools?
Winner of the Washingtonian great places to work, and Glassdoor #1 Company to Work For 2015! Have access to all of TMF's online and email products for FREE, and be paid for your contributions to TMF! Click the link and start your Fool career.